681823822	681823822	CD	B-NP	O
|	|	NN	I-NP	O
GVH	GVH	NN	I-NP	O
|	|	NN	I-NP	O
18813450	18813450	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8195834	8195834	CD	B-NP	O
|	|	CC	I-NP	O
3/24/2003	3/24/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
unstable	unstable	JJ	I-NP	O
angina	angina	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/23/2003	10/23/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/11/2003	5/11/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	B-protein
MERTA	MERTA	NNP	B-NP	I-protein
,	,	,	O	O
EDGARDO	EDGARDO	NNP	B-NP	O
566-31-14-1	566-31-14-1	CD	I-NP	O
Dieburb	Dieburb	NNP	I-NP	O
New	New	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
7/26/03	7/26/03	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MARQUIS	MARQUIS	NNP	B-NP	O
,	,	,	O	O
CLINTON	CLINTON	NNP	B-NP	O
TOD	TOD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/14	9/14	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NTG	NTG	NNP	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	SYM	O	O
NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
Q5MIN	Q5MIN	NN	I-NP	O
X	X	NN	I-NP	O
3	3	CD	I-NP	O
PRN	PRN	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
BACTRIM	BACTRIM	NNP	I-NP	O
DS	DS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TRIMETHOPRIM	TRIMETHOPRIM	NN	I-NP	O
/	/	SYM	B-NP	O
SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	NN	I-NP	O
DO	DO	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
Qweds	Qwed	NNS	I-NP	O
and	and	CC	O	O
sun	sun	NN	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/18	3/18	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
continue	continue	VB	B-VP	O
indefinitely	indefinitely	RB	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/14	9/14	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SUST	SUST	NNP	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

150	150	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

LISINOPRIL	LISINOPRIL	NN	B-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/19/03	11/19/03	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Jason	Jason	NNP	I-NP	O
Goates	Goates	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
Known	Known	NNP	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
unstable	unstable	JJ	I-NP	O
angina	angina	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
AAA	AAA	NN	B-NP	O
repair	repair	NN	I-NP	O
,	,	,	O	O
MI	MI	NN	B-NP	B-protein
X	X	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
UTIs	UTI	NNS	I-NP	O
,	,	,	O	O
CAP	CAP	NN	B-NP	B-protein
,	,	,	O	O
elevated	elevated	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
80	80	CD	I-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
MI	MI	NN	I-NP	I-protein
in	in	IN	B-PP	O
1988	1988	CD	B-NP	O
,	,	,	O	O
1991	1991	CD	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
prior	prior	JJ	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
last	last	RB	B-ADVP	O
in	in	IN	B-PP	O
1991	1991	CD	B-NP	O
and	and	CC	O	O
since	since	IN	B-PP	O
then	then	RB	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
chest	chest	JJ	B-NP	O
pain	pain	NN	I-NP	O
free	free	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
severe	severe	JJ	B-NP	O
retrosternal	retrosternal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
reports	report	VBZ	B-VP	O
,	,	,	O	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
angina	angina	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
as	as	IN	I-PP	O
severe	severe	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
local	local	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
and	and	CC	I-NP	O
enzymes	enzyme	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
CXR	CXR	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
widened	widen	VBN	B-NP	O
mediastinum	mediastinum	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
dissection	dissection	NN	B-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
CT	CT	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
read	read	VBN	I-VP	O
as	as	IN	B-PP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
dissection	dissection	NN	B-NP	O
in	in	IN	B-PP	O
ascending	ascend	VBG	B-VP	O
aorta	aorta	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
ISCH	ISCH	NN	B-NP	O
CCU	CCU	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
CT	CT	NN	I-NP	O
here	here	RB	B-ADVP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
dissection	dissection	NN	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
show	show	VB	I-VP	O
extensive	extensive	JJ	B-NP	O
calficiations	calficiation	NNS	I-NP	O
and	and	CC	O	O
luminal	luminal	JJ	B-NP	O
disease	disease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
aorta	aorta	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
free	free	JJ	B-ADJP	O
here	here	RB	B-ADVP	O
until	until	IN	B-SBAR	O
6/9	6/9	CD	B-NP	O
AM	AM	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
again	again	RB	B-ADVP	O
with	with	IN	B-PP	O
ST	ST	JJ	B-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
V3-V6	V3-V6	NN	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
pain	pain	NN	B-NP	O
free	free	JJ	B-ADJP	O
with	with	IN	B-PP	O
nitro	nitro	NN	B-NP	O
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
floor	floor	NN	I-NP	O
with	with	IN	B-PP	O
presumed	presume	VBN	B-NP	O
unstable	unstable	JJ	I-NP	O
angina	angina	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
anginal	anginal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
EKG	EKG	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
lack	lack	NN	B-NP	O
of	of	IN	B-PP	O
elevated	elevated	JJ	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
6/22/03	6/22/03	CD	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
EF	EF	NN	B-NP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
RWMA	RWMA	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
root	root	NN	I-NP	O
dissection	dissection	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
RV	RV	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
11/19/03	11/19/03	CD	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
via	via	IN	B-PP	O
radial	radial	JJ	B-NP	O
approach	approach	NN	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
3	3	CD	B-NP	O
vessel	vessel	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
aneursymal	aneursymal	JJ	B-NP	O
segment	segment	NN	I-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
diffuse	diffuse	JJ	B-NP	O
non	non	JJ	I-NP	O
critical	critical	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
disease	disease	NN	I-NP	O
distally	distally	RB	B-ADVP	O
,	,	,	O	O
occluded	occlude	VBD	B-VP	O
and	and	CC	I-VP	O
collateralized	collateralize	VBD	I-VP	O
D1	D1	NN	B-NP	O
,	,	,	O	O
occluded	occlude	VBD	B-VP	O
and	and	CC	I-VP	O
collateralized	collateralize	VBD	I-VP	O
OM2	OM2	NN	B-NP	B-protein
,	,	,	O	O
anterior	anterior	JJ	B-NP	O
takeoff	takeoff	NN	I-NP	O
RCA	RCA	NN	I-NP	O
with	with	IN	B-PP	O
serial	serial	JJ	B-NP	O
non-critical	non-critical	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
mid	mid	JJ	I-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
LAD	LAD	NN	I-NP	O
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
18mm	18mm	NN	I-NP	O
X	X	SYM	O	O
2.5	2.5	CD	B-NP	O
mm	mm	NN	I-NP	O
Cypher	Cypher	NNP	I-NP	O
stent	stent	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
results	result	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
lisinopril	lisinopril	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
started	start	VBN	I-VP	O
here	here	RB	B-ADVP	O
-LRB-	-LRB-	JJ	B-NP	O
nitrates	nitrate	NNS	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
-RRB-	-RRB-	NN	B-NP	O
.	.	.	O	O

Integrillin	Integrillin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
give	give	VB	I-VP	O
pericatheterization	pericatheterization	NN	B-NP	O
for	for	IN	B-PP	O
16	16	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Fasting	Fast	VBG	B-VP	O
lipid	lipid	NN	B-NP	O
profile	profile	NN	I-NP	O
on	on	IN	B-PP	O
3/18	3/18	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
Triglycerides	Triglyceride	NNS	B-NP	O
of	of	IN	B-PP	O
122	122	CD	B-NP	O
,	,	,	O	O
HDL	HDL	NN	B-NP	B-protein
28	28	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
low	low	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	O	O
normal	normal	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
122	122	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
CLDL	CLDL	NN	B-NP	B-protein
,	,	,	O	O
VLDL	VLDL	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
received	receive	VBD	B-VP	O
mucomyst	mucomyst	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
contrast	contrast	NN	I-NP	O
CT	CT	NN	I-NP	O
here	here	RB	B-ADVP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
normal	normal	JJ	I-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

GU	GU	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
UTIs	UTI	NNS	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
bactrim	bactrim	JJ	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
on	on	IN	B-PP	O
6/9	6/9	CD	B-NP	O
and	and	CC	I-NP	O
10/19	10/19	CD	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Dispo	Dispo	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
with	with	IN	B-PP	O
instruction	instruction	NN	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Alejandro	Alejandro	NNP	I-NP	O
Linkon	Linkon	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
VNA	VNA	NN	B-NP	O
instruction	instruction	NN	I-NP	O
for	for	IN	B-PP	O
BP	BP	NN	B-NP	O
checks	check	NNS	I-NP	O
and	and	CC	O	O
Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
For	For	IN	B-PP	O
patient	patient	NN	B-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
plavix	plavix	NN	B-NP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
1	1	CD	I-NP	O
year	year	NN	I-NP	O
and	and	CC	I-NP	O
work	work	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
PCP/Cardiologist	PCP/Cardiologist	NN	B-NP	O
whether	whether	IN	B-SBAR	O
or	or	CC	O	O
not	not	RB	O	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
indefinitely	indefinitely	RB	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
JANOS	JANOS	NNP	B-NP	O
,	,	,	O	O
JULIO	JULIO	NNP	B-NP	O
Z.	Z.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SM58	SM58	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/26/03	7/26/03	CD	I-NP	O
@	@	IN	B-NP	O
10	10	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

